Shorter All-Oral Regimens for Drug-Resistant TB are Cost-Effective in India: ICMR Study

• ICMR-NIRT economic evaluation in the Indian Journal of Medical Research found six-month all-oral BPaL/BPaLM regimens cost-effective vs. existing longer MDR/RR-TB regimens under NTEP.
• Relevant for UPSC under GS-II (Health) and GS-III (S&T) — links India's End TB 2025 target, Health Technology Assessment, and antimicrobial resistance.